Activation of the transcription factor ISGF3 by interferon-gamma.
about
Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon GammaSTAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptorDNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.Octamer-binding factor 6 (Oct-6/Pou3f1) is induced by interferon and contributes to dsRNA-mediated transcriptional responses.Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γApical role for BRG1 in cytokine-induced promoter assemblyA weak signal for strong responses: interferon-alpha/beta revisited.Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissueExpression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis.Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state.IκB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses.Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis.A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosisMice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells.Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice.Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.STAT2: A shape-shifting anti-viral super STATRegulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male miceDeciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.The role of signal transducer and activator of transcription-2 in the interferon response.Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention.STAT2 and IRF9: Beyond ISGF3.Antiviral activity of salmonid gamma interferon against infectious pancreatic necrosis virus and salmonid alphavirus and its dependency on type I interferon.Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.Immunological aspects of rabies: a literature review.Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.Transcriptional Repression of IFN Regulatory Factor 7 by MYC Is Critical for Type I IFN Production in Human Plasmacytoid Dendritic CellsThe Role of STAT Signaling Pathways in the Pathogenesis of Systemic Lupus Erythematosus.Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.
P2860
Q26779055-4F8944FC-BB70-4BFB-BCE0-940E1BBCC411Q27312177-8F329E7D-977E-437C-8182-C9789E26150DQ27469850-F23C5B85-98CD-4438-A246-10E55C1E739EQ33650327-06AF1A1E-5CE9-45FB-9676-B763D7071503Q33650938-D58C2559-42A7-454C-ABB8-F7B53E021A89Q33845465-BB727D04-E6A9-4269-B857-8B12F1B9D987Q33886711-A1D7EE75-E4FE-41B8-B2D8-C7AB3173A668Q34078375-348409D0-E156-4E2F-8C2D-E8A218DE5160Q34238056-130F97B8-6883-4071-B3CE-DE8A31140917Q34438000-8BEF66D3-B8FF-4853-94BA-C918DD9F5F44Q34742468-F8D3AA6F-BBCA-486E-BF7B-DD4FCA2E1050Q34992598-E95E19DD-4530-4899-A6E2-D4C40F92D6E2Q35106581-B13BD105-8916-4671-85FF-97D118F5E084Q35382729-83301440-8971-4C3E-A145-BFEA15856D6EQ35641446-455C649A-12F8-4202-83B9-8E9CE6995E3BQ35788671-35726461-F3E8-4345-9401-6B46AA4BF295Q35901899-AD7E3858-0ECE-4EA5-AB4E-ADBBCE48349CQ36086689-F0D8E422-BE55-4827-8A5C-9408CDBA9665Q36158559-9FB28540-2439-45E7-903D-9BD923AA1990Q36423925-D2F6A5D1-0670-4A6B-B2AE-449C6B2480ABQ36494607-BA4F8362-FC08-4479-9162-7971867E7E52Q36844749-99BF3173-6C40-4780-8D23-5262E9F35B96Q36895430-4FB26C24-8A09-42BD-A94E-33E273111524Q37071983-ADA37F29-0A8F-4E3A-8D82-99DEEEAF2984Q37078467-FC641AC5-D500-4F27-8BAD-897993FFD561Q37197803-2CB0BF98-29CC-4E20-A16E-D21D45D323DCQ37610453-DB7133FE-7A1D-4B31-B361-793E3221D859Q37978889-AB8923CF-81CC-47B5-ADB9-19D29907D4ECQ38052946-C7A82FA1-2AEB-4D2C-AA64-368F2A08DEFFQ38185399-1E2EFE67-0007-423E-9BB9-0789EE343217Q38286184-F735147C-C9A0-4DC5-9328-45DE55DE49D8Q38523847-3C446312-7F56-42EF-A1AD-348F48DE1C57Q38654706-976F6403-8214-45B4-BF1D-9D2B60896290Q38719410-5BFCDBAB-6DB8-4BA3-AA81-523036019485Q38746231-E4919CF4-7D8B-40FA-BEDF-927833AA97F7Q38842404-C93E6BA5-7F2E-4F23-A04B-EBA0DE66A55FQ39128976-E9C28036-BE38-4F24-B4B8-2FF296DFB805Q40140935-7524A556-E8D1-48A1-BB9C-C9FCCCABB221Q40467468-EC28620A-9912-4784-A30E-B80030F7EB0EQ40527857-BB0AA02C-F416-4DB7-A6B8-AA3FF5283C3D
P2860
Activation of the transcription factor ISGF3 by interferon-gamma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Activation of the transcription factor ISGF3 by interferon-gamma.
@en
type
label
Activation of the transcription factor ISGF3 by interferon-gamma.
@en
prefLabel
Activation of the transcription factor ISGF3 by interferon-gamma.
@en
P2093
P2860
P356
P1433
P1476
Activation of the transcription factor ISGF3 by interferon-gamma.
@en
P2093
Kitagawa M
Matsumoto M
Schindler C
Taniguchi T
P2860
P304
P356
10.1515/BC.1999.087
P577
1999-06-01T00:00:00Z